Publications

5891 Results

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women

Authors
S Luen;G Viale;S Nik-Zainal;P Savas;R Kammler;P Dell Orto;O Biasi;A Degasperi;L Brown;I Lang;G MacGrogan;C Tondini;M Bellet;F Villa;A Bernardo;E Ciruelos;P Karlsson;P Neven;M Climent;B Muller;W Joshum;H Bonnefoi;S Martino;N Davidson;C Geyer;B Walley;J Ingle;R Coleman;C Solbach;B Thurlimann;M Colleoni;A Coates;A Goldhirsch;GF Fleming;P Francis;T Speed;M Regan;S Lori
Journal / Conference
ANNALS OF ONCOLOGY
Year
2023
Research Committee(s)
Breast
PMID
PMID36709040

Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics

Authors
L Welter;S Zheng;S Setayesh;M Morikado;A Agrawal;R Nevarez;A Naghdloo;M Pore;N Higa;A Kolatar;P Sharma;H Moore;J Richer;A Elias;K Pienta;A Zurita;M Gross;S Shishido;J Hicks;C Velasco;P Kuhn
Journal / Conference
Cancers Aug 3;15(15):3949
Year
2023
Research Committee(s)
Breast
PMID
PMID37568766
PMC
PMC10417732
Study Number(s)
S1222, S1416

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Bronchoalveolar Carcinoma of the Lung (Cohort 12)

Authors
Y Chae;M Othus;S Patel;D Gerber;T Tanvetyanon;L Il-Young Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;C Blanke;R Kurzrock
Journal / Conference
WCLC Annual Meeting (September 9-12, 2023, Singapore), poster
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers (SWOG S1815; NCT#03768414)

Authors
R Shroff;K Guthrie;A Scott;M Borad;L Goff;K Matin;A Mahipal;A Kalyan;M Javle;C Aghajanian;B Tan;P Cheema;A Patel;R Iyer;R Kelley;J Thumar;A El-Khoueiry;EG Chiorean;H Hochster;PA Philip
Journal / Conference
J Clin Oncol 41, 2023 (suppl 4; abstr LBA490); ASCO GI Cancers Symposium (January 19-21, 2023, San Francisco, CA), oral
Year
2023
Research Committee(s)
Gastrointestinal
Study Number(s)
S1815

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The non-epithelial ovarian tumor cohort #13

Authors
Y Chae;M Othus;S Patel;K Wilkinson;E Whitman-Purves;J Lea;J Schallenkamp;N Adra;L Appleman;M Alden;J Thomes Pepin;J Ellerton;A Poklepovic;A Walter;M Rampurwala;L Il-Young Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
AACR Annual Meeting (April 14-19, 2023, Orlando, FL, poster
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The small cell carcinoma of the ovary, hypercalcemic type cohort #49

Authors
Y Chae;M Othus;S Patel;R Aljumaily;K Win;T Pejovic;S Thomas;L Il-Young Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
AACR Annual Meeting (April 14-19, 2023, Orlando, FL, poster
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Adjuvant everolimus in patients (pts) with completely resected very high-risk renal cell cancer (RCC) and clear cell histology: results from the phase III placebo-controlled SWOG S0931 (EVEREST) trial

Authors
PN Lara;C Tangen;E Heath;M Stein;M Meng;A Alva;S Pal;I Puzanov;J Clark;T Choueiri;N Agarwal;R Uzzo;N Haas;M Plets;U Vaishampayan;B Shuch;IM Thompson;C Ryan
Journal / Conference
Annals of Oncology VOLUME 34, SUPPLEMENT 2, S1015; ESMO (October 20-24, 2023, Madrid, Spain), poster
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S0931

Clinical outcomes and translational analysis of DART S1609: the thyroid cancer cohort; PD-1+ PD-L1+ TIL correlated with favorable survival

Authors
YK Chae;Y Lu;S Patel;C Rodriguez;A Onitilo;A Mattour;I Rybkin;S Fenton;L Il-Young Chung;H Kim;M Othus;E Parra;J Zhang;L Gomez;C Fernandez;L Soto;H Chen;G Manyam;D Duose;R Luthra;J Zhang;G Al-Atrash;I Wistuba;J Lee;J Zhang;C Haymaker;C McLeod;H Chen;E Sharon;C Ryan;G Lopez;M Plets;CD Blanke;R Kurzrock
Journal / Conference
SITC Annual Meeting (Nov. 1-5, 2023, San Diego, CA), poster
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency

Authors
S Stecklein;W Barlow;L Pusztai;K Timms;R Kennedy;G Logan;R Seitz;S Badve;Y Gokmen-Polar;P Porter;H Linden;D Tripathy;G Hortobagyi;A Godwin;A Godwin;A Thompson;D Hayes;P Sharma
Journal / Conference
JCO Precision Oncology Sep:7:e2300197. doi: 10.1200/PO.23.00197
Year
2023
Research Committee(s)
Breast
PMID
PMID37972336
PMC
PMC10681491
Study Number(s)
SWOG-9313

Mixed-methods analysis of physician genomic confidence in the pre-implementation phase of the cluster randomized trial evaluating genomic tumor boards (SWOG S2108CD, NCT05455606)

Authors
M Trivedi;J Rueter;J Unger;K Arnold;S Colby;A Michel;A Taboada;L Graham;K Reed;J Fischer;B Symington;S Ramsey;D Hershman
Journal / Conference
ASCO Quality Care Symposium (October 27-28, 2023, Boston, MA, poster; JCO Oncol Pract 19, 2023 (suppl 11; abstr 439)
Year
2023
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S2108CD